0.73
price up icon0.70%   0.0051
after-market Dopo l'orario di chiusura: .73
loading
Precedente Chiudi:
$0.7249
Aprire:
$0.7211
Volume 24 ore:
423.42K
Relative Volume:
2.22
Capitalizzazione di mercato:
$91.46M
Reddito:
-
Utile/perdita netta:
$-70.78M
Rapporto P/E:
-1.3036
EPS:
-0.56
Flusso di cassa netto:
$-61.27M
1 W Prestazione:
+1.67%
1M Prestazione:
-2.28%
6M Prestazione:
-56.55%
1 anno Prestazione:
-67.84%
Intervallo 1D:
Value
$0.7201
$0.776
Intervallo di 1 settimana:
Value
$0.6937
$0.8476
Portata 52W:
Value
$0.66
$3.09

Nautilus Biotechnology Inc Stock (NAUT) Company Profile

Name
Nome
Nautilus Biotechnology Inc
Name
Telefono
206-333-2001
Name
Indirizzo
2701 EASTLAKE AVE EAST, SEATTLE
Name
Dipendente
134
Name
Cinguettio
Name
Prossima data di guadagno
2024-10-29
Name
Ultimi documenti SEC
Name
NAUT's Discussions on Twitter

Confronta NAUT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
NAUT
Nautilus Biotechnology Inc
0.73 91.46M 0 -70.78M -61.27M -0.56
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.16 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
534.91 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.06 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
542.47 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.16 28.51B 3.81B -644.79M -669.77M -6.24

Nautilus Biotechnology Inc Stock (NAUT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-12-05 Downgrade Goldman Neutral → Sell
2024-06-27 Iniziato Guggenheim Buy
2024-06-03 Ripresa Jefferies Hold
2022-01-06 Iniziato Morgan Stanley Equal-Weight
2021-11-02 Iniziato Cowen Outperform
2021-08-04 Iniziato Goldman Neutral
2021-07-13 Iniziato Jefferies Buy
Mostra tutto

Nautilus Biotechnology Inc Borsa (NAUT) Ultime notizie

pulisher
Jun 14, 2025

Millennium Management LLC Purchases Shares of 37,704 Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

Jun 14, 2025
pulisher
Jun 13, 2025

Millennium Management LLC Has $171,000 Position in Codexis, Inc. (NASDAQ:CDXS) - Defense World

Jun 13, 2025
pulisher
Jun 11, 2025

26,324 Shares in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Purchased by Squarepoint Ops LLC - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

Home Product Center Public (OTCMKTS:HPCRF) Trading Up 20.5% – Should You Buy? - Defense World

Jun 11, 2025
pulisher
Jun 07, 2025

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Shares Bought by Jane Street Group LLC - Defense World

Jun 07, 2025
pulisher
Jun 04, 2025

Citadel Advisors LLC Raises Holdings in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

Jun 04, 2025
pulisher
Jun 02, 2025

Tenpoint Therapeutics Ltd. Appoints Melissa Epperly as Chief Financial Officer - Business Wire

Jun 02, 2025
pulisher
May 30, 2025

Northern Trust Corp Sells 32,695 Shares of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

May 30, 2025
pulisher
May 27, 2025

Nautilus Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewswire

May 27, 2025
pulisher
May 20, 2025

20,256 Shares in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Purchased by Cubist Systematic Strategies LLC - Defense World

May 20, 2025
pulisher
May 16, 2025

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Shares Acquired by Dimensional Fund Advisors LP - Defense World

May 16, 2025
pulisher
May 15, 2025

Nautilus Biotechnology And 2 Other Penny Stocks With Promising Potential - Yahoo Finance

May 15, 2025
pulisher
May 15, 2025

Insiders continue to buy Nautilus Biotechnology, Inc. (NASDAQ:NAUT) and now own 31% shares - simplywall.st

May 15, 2025
pulisher
May 13, 2025

Nautilus Biotechnology chief scientist buys $9,885 in common stock By Investing.com - Investing.com Nigeria

May 13, 2025
pulisher
May 13, 2025

Hsbc Holdings PLC Has $92,000 Position in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

May 13, 2025
pulisher
May 13, 2025

Barclays PLC Buys 19,030 Shares of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

May 13, 2025
pulisher
May 12, 2025

Nautilus Biotechnology chief scientist buys $9,885 in common stock - Investing.com

May 12, 2025
pulisher
May 12, 2025

Nautilus Biotechnology Co-founder and Chief Scientist Parag Mallick, Ph.D., Honored with the Academy for Radiology and Biomedical Imaging Research’s Distinguished Investigator Award - Barchart.com

May 12, 2025
pulisher
May 05, 2025

Renaissance Technologies LLC Acquires 95,521 Shares of Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

May 05, 2025
pulisher
May 04, 2025

JPMorgan Chase & Co. Raises Stake in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

May 04, 2025
pulisher
May 04, 2025

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Short Interest Update - Defense World

May 04, 2025
pulisher
Apr 30, 2025

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q1 2025 Earnings Call Transcript - Insider Monkey

Apr 30, 2025
pulisher
Apr 30, 2025

Nautilus Biotechnology Reports Q1 2025 Financial Results - TipRanks

Apr 30, 2025
pulisher
Apr 30, 2025

Nautilus Biotechnology targets late 2026 platform launch amid proteoform assay advancements - MSN

Apr 30, 2025
pulisher
Apr 29, 2025

Nautilus Biotech’s Earnings Call Highlights Progress and Promise - TipRanks

Apr 29, 2025
pulisher
Apr 29, 2025

Nautilus Biotechnology Reports First Quarter 2025 Financial Results - GlobeNewswire

Apr 29, 2025
pulisher
Apr 29, 2025

Earnings call transcript: Nautilus Biotechnology Q1 2025 surprises with EPS beat - Investing.com

Apr 29, 2025
pulisher
Apr 29, 2025

Nautilus Biotechnology (NAUT) Anticipates Tau Proteoform Assay L - GuruFocus

Apr 29, 2025
pulisher
Apr 29, 2025

Nautilus Biotechnology Posts Qtrly Loss Per Share $0.13 - marketscreener.com

Apr 29, 2025
pulisher
Apr 27, 2025

Nautilus Biotechnology (NAUT) Expected to Announce Quarterly Earnings on Tuesday - American Banking and Market News

Apr 27, 2025
pulisher
Apr 27, 2025

Nautilus Biotechnology (NAUT) to Release Earnings on Tuesday - Defense World

Apr 27, 2025
pulisher
Apr 25, 2025

Nautilus Biotechnology Inc expected to post a loss of 15 cents a shareEarnings Preview - TradingView

Apr 25, 2025
pulisher
Apr 23, 2025

Short Interest in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Increases By 20.5% - Defense World

Apr 23, 2025
pulisher
Apr 17, 2025

Wells Fargo & Company MN Sells 12,607 Shares of Commercial Metals (NYSE:CMC) - Defense World

Apr 17, 2025
pulisher
Apr 16, 2025

Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025 - The Manila Times

Apr 16, 2025
pulisher
Apr 05, 2025

Nautilus Biotechnology Appoints Mass Spectrometry Leader Ken Suzuki as Chief Marketing Officer - MarketScreener

Apr 05, 2025
pulisher
Apr 02, 2025

NAUT Stock Plummets to 52-Week Low at $0.82 Amid Market Turbulence By Investing.com - Investing.com South Africa

Apr 02, 2025
pulisher
Apr 02, 2025

NAUT Stock Plummets to 52-Week Low at $0.82 Amid Market Turbulence - Investing.com India

Apr 02, 2025
pulisher
Apr 02, 2025

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Stock Position Decreased by Charles Schwab Investment Management Inc. - Defense World

Apr 02, 2025
pulisher
Apr 02, 2025

Virtu Financial LLC Takes $28,000 Position in Nautilus Biotechnology, Inc. (NASDAQ:NAUT) - Defense World

Apr 02, 2025
pulisher
Mar 31, 2025

We're Keeping An Eye On Nautilus Biotechnology's (NASDAQ:NAUT) Cash Burn Rate - Yahoo Finance

Mar 31, 2025
pulisher
Mar 12, 2025

Nautilus Biotechnology: Hold Rating Amid Delayed Launch and Strategic Adjustments - TipRanks

Mar 12, 2025
pulisher
Mar 03, 2025

Nautilus Biotechnology’s Earnings Call: Progress Amid Challenges - TipRanks

Mar 03, 2025
pulisher
Mar 03, 2025

Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 03, 2025
pulisher
Mar 01, 2025

Nautilus Biotechnology lays off 16% of workforce, plans release of commercial platform in 2026 - MSN

Mar 01, 2025
pulisher
Feb 28, 2025

Nautilus: Trading Below An Albeit Lower Net Cash Figure (NASDAQ:NAUT) - Seeking Alpha

Feb 28, 2025
pulisher
Feb 28, 2025

Guggenheim cuts Nautilus Biotech target to $2.50, keeps buy rating - Investing.com

Feb 28, 2025

Nautilus Biotechnology Inc Azioni (NAUT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Nautilus Biotechnology Inc Azioni (NAUT) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Mallick Parag
Chief Scientist
May 08 '25
Buy
0.73
12,000
8,788
20,491,892
Mallick Parag
Chief Scientist
May 12 '25
Buy
0.73
1,500
1,098
20,493,392
Patel Sujal M
CEO, President, and Secretary
Mar 19 '25
Buy
0.99
53,300
53,028
10,117,788
Patel Sujal M
CEO, President, and Secretary
Mar 20 '25
Buy
1.00
23,933
23,890
10,141,721
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
Capitalizzazione:     |  Volume (24 ore):